Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
VEGF
>>
Phase 3
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
13
26
39
52
65
78
91
104
117
130
Recentin
(cediranib) / AstraZeneca
famitinib
(SHR 1020) / Jiangsu Hengrui Pharma
Rydapt
(midostaurin) / Novartis
dovitinib
(TKI258) / Novartis, Oncoheroes
vatalanib
(PTK787) / Novartis, Bayer
sitravatinib
(MGCD516) / BeiGene
Balversa
(erdafitinib) / J&J
Fotivda
(tivozanib) / Kyowa Kirin, Jazz, LG Chem
semaxanib
(SU5416) / Pfizer
ivonescimab
(AK112) / Akesobio, Summit Therap
lucitanib
(E 3810) / Clovis, Servier
brivanib alaninate
(BMS-582664) / ZAI Lab
motesanib
(AMG 706) / Takeda
Fumena
(vorolanib) / Tyrogenex, Betta Pharma
Aplidin
(plitidepsin) / PharmaMar, Roche
linifanib
(ABT-869) / AbbVie
BNT327
/ BioNTech
chiauranib
(CS 2164) / Chipscreen
tesevatinib
(KD019) / Sanofi
Byvasda
(bevacizumab biosimilar) / Innovent Biologics, Etana
Qinlock
(ripretinib) / Deciphera
Hanbeitai
(bevacizumab biosimilar) / Fosun Pharma
Rayoqta
(abicipar pegol) / Molecular Partners
Zaltrap intravitreal
(ziv-aflibercept intravitreal) / Regeneron, Sanofi
tarcocimab tedromer
(KSI 301) / Kodiak Sciences
AL2846
/ Advenchen, Sino Biopharm
RGX-314
/ REGENXBIO, AbbVie
genakumab
(Gensci048) / GeneScience
tinengotinib
(TT-00420) / TransThera Biosci
zanzalintinib
(XL092) / Exelixis
BAT5906
/ Bio-Thera Solutions
efdamrofusp alfa
(IBI-302) / Innovent Biologics
emvododstat
(PTC299) / PTC Therap
muparfostat
(PI-88) / Cellxpert Biotechnology Corp
suvemcitug
(APX003) / Mabwell (Shanghai) Biosci, Pyxis Oncology
601A
/ 3SBio
Evizon
(squalamine) / NeuBase Therap
RC28-E
/ Rongchang Pharma
navixizumab
(OMP-305B83) / Feng Biosci
sozinibercept
(OPT-302) / Opthea
triamcinolone acetonide + anti-VEGF
(CLS-1003) / Clearside Biomedical
AL8326
/ Advenchen
CTX-009
/ ABL Bio, Compass Therap
Eylea HD
(high-dose aflibercept) / Regeneron, Bayer
KC1036
/ Konruns Pharma
Lytenava
(bevacizumab-vikg) / Outlook Therap
Zirabev
(bevacizumab-bvzr) / Pfizer
metformin/rosuvastatin
(JLP1310) / Jeil
pembrolizumab/hyaluronidase
(MK-3475A) / Merck (MSD)
Avegra
(bevacizumab biosimilar) / Biocad
1
2
»
